Cumulative Number of Skin Regenerative Medicine Treatments Exceeds 200 at CellBank Corp.'s Partner Clinic 'Ozaki Clinic LUXE Shinjuku'

In accordance with the 'Act on the Safety of Regenerative Medicine', our company obtained a license for manufacturing specified cell products from the Ministry of Health, Labour and Welfare in 2015. Upon request from medical institutions providing regenerative medicine, we contract the manufacturing and storage of cell products at our CPC (Cell Processing Center). Our mission is to become a leading company in the regenerative medicine field by rapidly and efficiently providing technologies and services to society.